FZMD - Fuse Medical, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.5000
0.0000 (0.00%)
As of 3:46PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.5000
Open0.5000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5000 - 0.5000
52 Week Range0.3000 - 1.1000
Volume2,000
Avg. Volume103
Market Cap35.111M
Beta (3Y Monthly)2.62
PE Ratio (TTM)8.33
EPS (TTM)0.0600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wirelast month

    Fuse Medical Reports First Quarter 2019 Results

    Fuse Medical, Inc., (FZMD), a distributor and an emerging manufacturer of medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2019, with the United States Securities and Exchange Commission, on Tuesday, May 7, 2019. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to announce improvements in our first quarter of 2019 results, with an eleven (11) percentage point increase to gross profit and one (1) percentage point improvement in earnings, as a percentage of net revenues, compared to the same period one year ago. The filing can be found on the Company’s website at http://www.fusemedical.com/investors.

  • Business Wire3 months ago

    Fuse Medical Reports Full Year 2018 Financial Results with Record Earnings

    Fuse Medical, Inc., , an emerging manufacturer and distributor of medical devices for the orthopedic and spine marketplace, announced record earnings for the fiscal year ended December 31, 2018.

  • Business Wire3 months ago

    OTC Markets Lists Securities of Fuse Medical, Inc. as Exempt from Penny Stock Designation

    Fuse Medical, Inc., , , announced that OTC Markets has identified Fuse as “Penny Stock Exempt,” meaning that shares of Fuse’s common stock, par value $0.01 per share , is no longer a “Penny Stock” as defined in Rule 3a51-1, promulgated under the Securities Exchange Act of 1934, as amended.

  • Business Wire7 months ago

    Fuse Medical, Inc. Ranked No. 56 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500TM

    Fuse Medical, Inc., , , a contract manufacturer and national distributor of medical devices, announced that it has been named Number 56 on the Deloitte’s 2018 Technology Fast 500TM , an annual ranking of the fastest growing North American companies in the technology, media, telecommunications, life sciences and energy tech sectors.

  • Business Wire7 months ago

    Fuse Medical, Inc. Files Quarterly Report on Form 10-Q

    Fuse Medical, Inc., , , announced that it has filed its quarterly report on Form 10-Q for the third quarter ended September 30, 2018 of the Fiscal Year 2018 with the United States Securities and Exchange Commission, on Tuesday November 13, 2018.

  • Business Wire10 months ago

    Fuse Medical, Inc. Completes Acquisition of Maxim Surgical

    Fuse Medical, Inc. , announced the completion of the acquisition of Palm Springs Partners, LLC d/b/a Maxim Surgical , a manufacturing company in the spinal fusion device market and full-service medical device and distribution company .